111 related articles for article (PubMed ID: 1385177)
1. The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels.
Schmidt AW; McLean S; Heym J
Eur J Pharmacol; 1992 Sep; 219(3):491-2. PubMed ID: 1385177
[TBL] [Abstract][Full Text] [Related]
2. The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences.
Guard S; Boyle SJ; Tang KW; Watling KJ; McKnight AT; Woodruff GN
Br J Pharmacol; 1993 Sep; 110(1):385-91. PubMed ID: 7693284
[TBL] [Abstract][Full Text] [Related]
3. Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist.
McLean S; Ganong AH; Seeger TF; Bryce DK; Pratt KG; Reynolds LS; Siok CJ; Lowe JA; Heym J
Science; 1991 Jan; 251(4992):437-9. PubMed ID: 1703324
[TBL] [Abstract][Full Text] [Related]
4. A selective and potent antagonist of substance P receptors on pancreatic acinar cells.
Sjödin L; Gylfe E
Biochem Int; 1992 Jun; 27(1):145-53. PubMed ID: 1378274
[TBL] [Abstract][Full Text] [Related]
5. A potent nonpeptide antagonist of the substance P (NK1) receptor.
Snider RM; Constantine JW; Lowe JA; Longo KP; Lebel WS; Woody HA; Drozda SE; Desai MC; Vinick FJ; Spencer RW
Science; 1991 Jan; 251(4992):435-7. PubMed ID: 1703323
[TBL] [Abstract][Full Text] [Related]
6. Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.
Homaidan FR; Donowitz M; Weiland GA; Sharp GW
Am J Physiol; 1989 Jul; 257(1 Pt 1):G86-93. PubMed ID: 2473655
[TBL] [Abstract][Full Text] [Related]
7. Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats.
Snider RM; Longo KP; Drozda SE; Lowe JA; Leeman SE
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10042-4. PubMed ID: 1719543
[TBL] [Abstract][Full Text] [Related]
8. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
[TBL] [Abstract][Full Text] [Related]
9. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
Boles RG; Yamamura HI; Schoemaker H; Roeske WR
J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
[TBL] [Abstract][Full Text] [Related]
10. Species differences in affinities of non-peptide antagonists for substance P receptors.
Gitter BD; Waters DC; Bruns RF; Mason NR; Nixon JA; Howbert JJ
Eur J Pharmacol; 1991 May; 197(2-3):237-8. PubMed ID: 1717291
[No Abstract] [Full Text] [Related]
11. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.
Goll A; Ferry DR; Striessnig J; Schober M; Glossmann H
FEBS Lett; 1984 Oct; 176(2):371-7. PubMed ID: 6092142
[TBL] [Abstract][Full Text] [Related]
12. FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
Morimoto H; Murai M; Maeda Y; Yamaoka M; Nishikawa M; Kiyotoh S; Fujii T
J Pharmacol Exp Ther; 1992 Jul; 262(1):398-402. PubMed ID: 1378096
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of neurogenic plasma exudation in guinea-pig airways by CP-96,345, a new non-peptide NK1 receptor antagonist.
Lei YH; Barnes PJ; Rogers DF
Br J Pharmacol; 1992 Feb; 105(2):261-2. PubMed ID: 1373095
[TBL] [Abstract][Full Text] [Related]
14. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
Floch A; Fardin V; Cavero I
Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
[TBL] [Abstract][Full Text] [Related]
15. CP-060S interacts with three principal binding sites on the L-type Ca2+ channel.
Suzuki Y; Tamura K; Adachi Y; Fukazawa M; Kato T
Eur J Pharmacol; 1998 Jan; 342(2-3):347-51. PubMed ID: 9548407
[TBL] [Abstract][Full Text] [Related]
16. Antagonists that demonstrate species differences in neurokinin-1 receptors.
Appell KC; Fragale BJ; Loscig J; Singh S; Tomczuk BE
Mol Pharmacol; 1992 Apr; 41(4):772-8. PubMed ID: 1373802
[TBL] [Abstract][Full Text] [Related]
17. Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors.
Gether U; Yokota Y; Emonds-Alt X; Brelière JC; Lowe JA; Snider RM; Nakanishi S; Schwartz TW
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6194-8. PubMed ID: 7687062
[TBL] [Abstract][Full Text] [Related]
18. Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels.
Melena J; Wood JP; Osborne NN
Eur J Pharmacol; 1999 Aug; 378(3):317-22. PubMed ID: 10493108
[TBL] [Abstract][Full Text] [Related]
19. CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptor.
McLean S; Snider RM; Desai MC; Rosen T; Bryce DK; Longo KP; Schmidt AW; Heym J
Regul Pept; 1993 Jul; 46(1-2):329-31. PubMed ID: 8210497
[No Abstract] [Full Text] [Related]
20. Effects of CP-96,345, a novel non-peptide antagonist of NK1 receptor, on the peristalsis in isolated guinea pig ileum.
Suzuki N; Gomi Y
Jpn J Pharmacol; 1992 Apr; 58(4):473-7. PubMed ID: 1328736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
